# Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC

> **NCT06472713** · PHASE2 · RECRUITING · sponsor: **Ming-Yuan Chen** · enrollment: 32 (estimated)

## Conditions studied

- Recurrent or Metastatic Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Mitoxantrone hydrochloride liposome injection
- **DRUG:** PD-1 Inhibitors

## Key facts

- **NCT ID:** NCT06472713
- **Lead sponsor:** Ming-Yuan Chen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-20
- **Primary completion:** 2025-10-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472713, "Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06472713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*